Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Surrozen (SRZN) EBITDA (2021 - 2025)

Surrozen (SRZN) has 5 years of EBITDA data on record, last reported at -$10.9 million in Q3 2025.

  • For Q3 2025, EBITDA fell 659.07% year-over-year to -$10.9 million; the TTM value through Sep 2025 reached -$57.5 million, down 29.37%, while the annual FY2024 figure was -$63.6 million, 48.51% down from the prior year.
  • EBITDA reached -$10.9 million in Q3 2025 per SRZN's latest filing, down from -$9.0 million in the prior quarter.
  • Across five years, EBITDA topped out at -$592000.0 in Q4 2022 and bottomed at -$28.0 million in Q4 2024.
  • Average EBITDA over 5 years is -$11.9 million, with a median of -$10.9 million recorded in 2025.
  • Peak YoY movement for EBITDA: skyrocketed 96.07% in 2022, then tumbled 1405.74% in 2023.
  • A 5-year view of EBITDA shows it stood at -$15.1 million in 2021, then surged by 96.07% to -$592000.0 in 2022, then crashed by 1405.74% to -$8.9 million in 2023, then crashed by 214.55% to -$28.0 million in 2024, then soared by 61.18% to -$10.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$10.9 million in Q3 2025, -$9.0 million in Q2 2025, and -$9.6 million in Q1 2025.